Califf Gets Unanimous Committee Vote Supporting FDA Commissioner Bid
This article was originally published in Clinica
After being thoroughly questioned, Robert Califf won a unanimous vote in support of his bid to become the next FDA commissioner from the Senate Health, Education, Labor and Pensions Committee on Jan. 12. Califf, who currently serves as FDA's deputy commissioner for medical products and tobacco, still requires full Senate approval and is likely to find some challenges there.
You may also be interested in...
Robert Califf’s nomination to be the next US FDA commissioner squeaked out of the Senate health committee, but a significant number of Republicans are against his confirmation over the agency’s recent decisions on abortion drugs.
Based on top-line Phase III data for garadacimab, CSL is preparing to submit the Factor XIIa inhibitor for US FDA approval for monthly prophylaxis of hereditary angioedema and expand the firm’s HAE franchise.
FDA says warning to VPR Brands could be its first move to reign in sales of nicotine gummies. Statements on brand’s site could indicate sales of nicotine gummies for smoking cessation are on the rise even though the claim isn’t approved.